Health Trends to Watch in 2025

Weight Loss Drugs and Shifting Buying Behaviors Push More Companies Into D2C Healthcare

Download
Share
About This Report
Healthcare and pharma companies are embracing D2C business models to get their medications, treatments, and services to more consumers without industry middlemen restricting access. Concurrently, patients are becoming more price-conscious healthcare shoppers, propelling more D2C activity next year.

Healthcare and pharma companies are selling more medical services and treatments directly to consumers online. Yet D2C’s rise in this sector is creating conflict between incumbents and upstarts, particularly around trendy weight loss drugs. Patients’ willingness to comparison shop for healthcare suggests escalating D2C activity in 2025.

Here’s what’s in the full report

1file

Exportable files for easy reading, analysis and sharing.

3charts

Reliable data in simple displays for presentations and quick decision making.

Table of Contents

  1. D2C will become a viable distribution channel for healthcare and pharma companies
  2. The clash between Big Pharma and some D2C weight loss drug sellers will worsen
  1. The cost of healthcare will drive more consumers to become price-conscious
  2. Sources
  1. Media Gallery

Access All Charts and Data

Gain access to reliable data presented in clear and intelligible displays for quick understanding and decision making on the most important topics related to your industry, included at no extra cost.

First Published on Dec 13, 2024

authors

Dane Finley, and Rajiv Leventhal

Contributors

Vladimir de Leon
Chart Editor
Jennifer Pearson
VP, Research
Heather Sprung
Senior Editor
Emman Velasco
Chart Editor
Paul Verna
VP, Content
Ali Young
Senior Copy Editor